Relapsed classic Hodgkin lymphoma with decreased CD30 expression after brentuximab and anti-CD30 CAR-T therapies. Kim DH, Vega F. Blood 2022;139:951.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kim DH, Vega F. Relapsed classic Hodgkin lymphoma with decreased CD30 expression after brentuximab and anti-CD30 CAR-T therapies. Blood 2022;139:951.
PMID: 35142847